ES-135

N/A

Report date: 2024/10/24 15:43:32

Base Information

Drug NameES-135
Drug Alias NameES-135EUSOL-rhFGF1ES-1601ES-1602ES-1801 +[8] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionFibroblast growth factors modulators
TargetsFibroblast growth factors
Therapy Area/IndicationsWounds and InjuriesHyperglycemiaHair Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEusol Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEusol Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperglycemiaHair DiseasesCarpal Tunnel Syndrome +[4] 
Inactive IndicationsWounds and InjuriesSpinal Cord Injuries

Other Information

ATC CodeN/A
Related LinksN/A